Aurinia Pharmaceuticals Inc. Return On Equity in % from Q3 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q3 2020 to Q3 2025.
  • Aurinia Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2025 was 21.8 %.
  • Aurinia Pharmaceuticals Inc. annual Return On Equity for 2024 was 1.54 %.
  • Aurinia Pharmaceuticals Inc. annual Return On Equity for 2023 was -20.1 %, a 21% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Return On Equity for 2022 was -25.4 %, a 48% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

Aurinia Pharmaceuticals Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 21.8 +27.9 Jul 1, 2025 Sep 30, 2025
Q2 2025 16.7 +30.2 Apr 1, 2025 Jun 30, 2025
Q1 2025 10.8 +27.2 Jan 1, 2025 Mar 31, 2025
Q4 2024 1.54 +21.7 Oct 1, 2024 Dec 31, 2024
Q3 2024 -6.05 +13.5 +69% Jul 1, 2024 Sep 30, 2024
Q2 2024 -13.5 +4.57 +25.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -16.5 +7.11 +30.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -20.1 +5.34 +21% Oct 1, 2023 Dec 31, 2023
Q3 2023 -19.5 +6.49 +24.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -18.1 +20 +52.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -23.6 +19.6 +45.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -25.4 +23.5 +48% Oct 1, 2022 Dec 31, 2022
Q3 2022 -26 +18.2 +41.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -38 +0.84 +2.16% Apr 1, 2022 Jun 30, 2022
Q1 2022 -43.2 -8.01 -22.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -48.9 -18.6 -61.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -44.2 -2.75 -6.63% Jul 1, 2021 Sep 30, 2021
Q2 2021 -38.9 Apr 1, 2021 Jun 30, 2021
Q1 2021 -35.2 Jan 1, 2021 Mar 31, 2021
Q4 2020 -30.3 Oct 1, 2020 Dec 31, 2020
Q3 2020 -41.5 Jul 1, 2020 Sep 30, 2020

Aurinia Pharmaceuticals Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 1.54 +21.7 Jan 1, 2024 Dec 31, 2024
2023 -20.1 +5.34 +21% Jan 1, 2023 Dec 31, 2023
2022 -25.4 +23.5 +48% Jan 1, 2022 Dec 31, 2022
2021 -48.9 -18.6 -61.3% Jan 1, 2021 Dec 31, 2021
2020 -30.3 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.